Cholley-Roulleau Martin, Bouju Yves, Lecoq Flore-Anne, Fournier Alexandre, Bellemère Philippe
Department of Hand Surgery, Plastic and Reconstructive Surgery, Centre Chirurgical Émile Gallé, CHU Nancy, Nancy, France.
Department of Hand Surgery, Institut de la main Nantes-Atlantique, Santé Atlantique, Saint-Herblain, France.
J Wrist Surg. 2021 Aug 11;11(3):262-268. doi: 10.1055/s-0041-1733877. eCollection 2022 Jun.
Isolated scaphotrapeziotrapezoid (STT) osteoarthritis (OA) mainly develops in women over 50 years of age in a bilateral manner. Many surgical treatments are available, including distal scaphoid resection with or without interposition, trapeziectomy, and STT arthrodesis. However, there is a controversy about which procedure is the most effective. The purpose of this study was to report the outcomes of the Pyrocardan implant for treating STT isolated OA at a mean follow-up of 5 years. Consecutive patients who underwent STT arthroplasty using the Pyrocardan were reviewed retrospectively by an independent examiner who performed a clinical and radiological evaluation. The mean follow-up time was 5 years (range 3-8 years). Thirteen patients (76%) were followed for more than 5 years. Between the preoperative assessment and the last follow-up, pain levels decreased significantly. There was no significant difference in the mean Kapandji opposition score. Grip and pinch strengths were 88 and 91% of the contralateral side. The active range of motion in flexion-extension and radioulnar deviation was not significantly different to the contralateral side (119° vs. 121° and 58° vs. 52°, > 0.1). Functional scores were improved significantly. No identifiable differences were found in the radioscaphoid, capitolunate, and scapholunate angles before and after surgery. In three cases, the preoperative dorsal intercalated scapholunate instability (DISI) failed to be corrected. In one case, DISI appeared after the procedure. There was one asymptomatic dislocation of the implant. Calcification around the trapezium and/or distal scaphoid was found in four cases. The survival rate of the implant without reoperation was 95%. In the medium term, Pyrocardan implant is an effective treatment for STT OA as it reduces pain, increases grip strength, and maintains wrist mobility. This is consistent with the results of other published case series using pyrocarbon implants. It provides a high rate of patient satisfaction. Nevertheless, the surgical procedure must be done carefully to avoid STT ligament damage, periarticular calcifications, or dislocation.
孤立性舟大多角小多角骨(STT)骨关节炎(OA)主要发生于50岁以上的女性,多为双侧发病。目前有多种手术治疗方法,包括带或不带植入物的舟骨远端切除术、大多角骨切除术和STT关节融合术。然而,关于哪种手术最为有效仍存在争议。
本研究的目的是报告Pyrocardan植入物治疗孤立性STT OA,平均随访5年的结果。
由一名独立检查者对连续接受Pyrocardan植入的STT关节成形术患者进行回顾性研究,该检查者进行了临床和影像学评估。
平均随访时间为5年(范围3 - 8年)。13例患者(76%)随访时间超过5年。术前评估与末次随访之间,疼痛程度显著降低。Kapandji对掌评分均值无显著差异。握力和捏力分别为对侧的88%和91%。屈伸和桡尺偏的主动活动范围与对侧无显著差异(119°对121°,58°对52°,P>0.1)。功能评分显著改善。手术前后桡舟、头月和舟月角未见明显差异。3例患者术前背侧插入型舟月不稳(DISI)未得到纠正。1例患者术后出现DISI。有1例植入物无症状性脱位。4例患者在大多角骨和/或舟骨远端周围发现钙化。未再次手术的植入物生存率为95%。
从中期来看,Pyrocardan植入物是治疗STT OA的有效方法,因为它能减轻疼痛、增加握力并保持腕关节活动度。这与其他发表的使用热解碳植入物的病例系列结果一致。它能使患者满意度较高。然而,手术操作必须谨慎,以避免STT韧带损伤、关节周围钙化或脱位。